During the past decade, Sendai Kousei Hospital conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 24 clinical trials were completed, i.e. on average, 47.1% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 20 clinical trials were completed. i.e. 90.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sendai Kousei Hospital" #1 sponsor was "Hoffmann-La Roche" with 16 trials, followed by "Abbott Medical Devices" with 5 trials sponsored, "Daiichi Sankyo, Inc." with 5 trials sponsored, "Takeda" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sendai Kousei Hospital" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Sendai Kousei Hospital" are "Non-Small Cell Lung Cancer" (7 trials), "Carcinoma, Non-Small-Cell Lung" (6 trials), "Coronary Artery Disease" (4 trials), "ALK-positive Advanced NSCLC" (2 trials) and "Aortic Valve Stenosis" (2 trials). Many other conditions were trialed in "Sendai Kousei Hospital" in a lesser frequency.

Most popular intervention types in "Sendai Kousei Hospital" are "Drug" (39 trials), "Device" (17 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Carboplatin" (8 trials), "Cisplatin" (7 trials), "Pemetrexed" (7 trials) and "Placebo" (7 trials). Other intervention names were less common.

The vast majority of trials in "Sendai Kousei Hospital" are 59 trials for "All" genders.

Currently, there are NaN active trials in "Sendai Kousei Hospital". undefined are not yet recruiting, 16 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Sendai Kousei Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sendai Kousei Hospital, 3 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".